JCS/JHRS 2024 Guideline Focused Update on Management of Cardiac Arrhythmias

Recommendations

Verbatim, with grade of recommendation or strength of consensus where given.

Contents of the original publication

The section headings of the original.

• TABLE OF CONTENTS
• FOREWORD
• On the Focus Update
• Recommended Class and Level of Evidence
• Clinical Questions
• Providing Information to the Public and Patients
• IMPLANTABLE CARDIAC ELECTRICAL DEVICES
• INDICATIONS FOR PRIMARY PREVENTION OF IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICDS)
• Elderly Patients (Table 3)
• Risk Factors for Fatal Arrhythmias and ICD Indications (Table 3)
• Ischemic Cardiomyopathy
• Non‐Ischemic Cardiomyopathy (Table 3)
• ICD INDICATIONS FOR CARDIAC SARCOIDOSIS
• Clinical Features of Cardiac Sarcoidosis
• Factors Associated With the Development of VT/VF
• Usefulness of ICD for Cardiac Sarcoidosis
• LEADLESS PACEMAKER
• Applicable Age
• Safety
• New Leadless Pacemaker
• VDD Mode
• Risk Assessment of Complications
• Leadless Pacemaker as a Replacement After Device Removal
• PACEMAKER THERAPY FOR REFLEX SYNCOPE
• FUTURE ADVANCES IN IMPLANTABLE CARDIAC ELECTRICAL DEVICES
• CONDUCTION SYSTEM PACING (CSP)
• Definition of CSP
• Features and Differences Between HBP and LBBAP
• Systems Used for CSP
• Indications for CSP in Patients With Bradycardia
• Patients With Conduction System Disturbance and Heart Failure (CRT Indication)
• Patients Requiring Atrioventricular Junction Ablation
• CRT FOR MID‐RANGE QRS
• Lower Limit of QRS Duration for CRT Indication
• Recommendations
• CATHETER ABLATION
• CATHETER ABLATION PROCEDURES FOR ATRIAL FIBRILLATION IN ADDITION TO PULMONARY VEIN ISOLATION (TABLE 11)
• Additional Ablation to PVI for Non‐PV Substrates
• Left Atrial Posterior Wall Isolation
• Low Voltage Area Ablation
• Chemical Ablation of the Vein of Marshall
• Other Additional Ablation Strategy
• EXPANDED INDICATION FOR ATRIAL FIBRILLATION CATHETER ABLATION
• Atrial Fibrillation Catheter Ablation as First‐Line Treatment
• Indications for Catheter Ablation of Asymptomatic Atrial Fibrillation
• Catheter Ablation for Atrial Fibrillation in the Patients With Heart Failure
• Angioplasty for Pulmonary Vein Stenosis After Atrial Fibrillation Catheter Ablation
• NEW ABLATION THERAPY FOR ATRIAL FIBRILLATION: PULSED FIELD ABLATION
• Principles and Properties
• Clinical Data
• Safety
• Outlook
• ADVANCES IN VENTRICULAR PREMATURE CONTRACTION (PVC) / VENTRICULAR TACHYCARDIA (VT) ABLATION
• Evaluation of Arrhythmic Substrate in PVC / VT Patients
• Indication and Timing
• New Ablation Techniques
• ATRIAL FIBRILLATION PHARMACOTHERAPY AND COMPREHENSIVE MANAGEMENT
• JAPANESE ORIGINAL STROKE RISK ASSESSMENT TOOL: HELT‐E2S2 SCORE
• HELT‐E2S2 Score Development Background
• HELT‐E2S2 Score
• HELT‐E2S2 Score and Existing Risk Scores: Comparison and Consistency
• ANTICOAGULATION FOR HIGH‐RISK OLDER PATIENTS
• Renal Dysfunction
• Low Body Weight
• Frailty
• Dementia
• Polypharmacy
• Concomitant Antiplatelet Agents (Table 22)
• Edoxaban 15 mg for the Very Old at High Bleeding Risk (Table 23)
• SPECIFIC NEUTRALIZERS FOR FACTOR XA INHIBITORS
• DIGITALIS AND ATRIAL FIBRILLATION
• Precautions in the Use of Digitalis
• ATRIAL FIBRILLATION AND LIFESTYLE MANAGEMENT / COMPREHENSIVE MANAGEMENT
• Atrial Fibrillation and Lifestyle Management
• Comprehensive Management of Patients With Atrial Fibrillation